Repaglinide

Composition

Single tablet of Repaglinide 0.5mg/1mg/2mg/3mg/4mg contain repaglinide I.P equivalent to Repaglinide 0.5mg/1mg/2mg/3mg/4mg

Indications

It is indicated to control blood sugar levels in type 2 diabetes

Side effects

Mild to moderate side effects have been observed such as weight gain, joint pain, diarrhea, increased urination, trouble breathing, blurred vision

Precautions

This drug is to be cautiously used in patients with kidney disease, liver disease, pregnancy, and lactation, do not drive and use machinery as this drug causes blurred vision

Contraindications

Use of this drug is contraindicated in patients with type 1 diabetes and diabetic ketoacidosis, liver dysfunction , use of clopidogrel and NPH insulin patients

Dosage and administration

In adults the usual dose consists of a tablet of 0.5 to 4mg given two to three times daily 30 minutes before a meal

Countries

We have also established roots and begun this new venture in other countries as well such as Jordan, Indonesia , and Oman

Available Forms

Manufacturing Services

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai